Protective effect of taxifolin against prooxidant and proinflammatory kidney damage associated with acrylamide in rats

ArticleAçık Erişim

Özet

The current study investigates the biochemical and histopathological effects of taxifolin on acrylamide-induced kidney damage. A 50 mg/kg dose of taxifolin was administered via oral gavage to the taxifolin + acrylamide (TACR) group (n-6) consisting of male albino Wistar rats. The same volume of distilled water used as solvent was orally administered to the acrylamide (ACR) (n-6) and healthy (HG) (n-6) groups. One hour after the administration of taxifolin and distilled water, a 20 mg/kg dose of acrylamide was orally administered to the TACR and ACR groups. This procedure was repeated once a day for 30 days. In the acrylamide group, malondialdehyde (MDA), tumour necrosis factor-alpha (TNF-α), and interleukin-1 beta (IL-1β) levels were found to be high, total glutathione (tGSH) levels were found to be low, and there was severe interstitial haemorrhage; additionally, tubular necrosis, tubular atrophy, leucocyte infiltration, and glomerular structures with expanded Bowman's space were observed. In the taxifolin group, where the increase of MDA, IL-1β, and TNF-α and the decrease of tGSH associated with acrylamide have been prevented, any histopathological finding other than mild necrosis and atrophic tubules was not found. This suggests that Taxifolin would prevent kidney tissue from acrylamide-induced damage would be effective in treating acrylamide-induced nephrotoxicity, inhibiting the increase of MDA, IL-1β and TNF-α, and decreasing tGSH associated with acrylamide. © 2021

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/13070Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorBedir, Fevzi
dc.contributor.authorKocatürk, Hüseyin
dc.contributor.authorYapanoğlu, Turgut
dc.contributor.authorGürsul, Cebrail
dc.contributor.authorArslan, Remzi
dc.contributor.authorMammadov, Renad
dc.contributor.authorÇoban, Abdülkadir
dc.contributor.authorAltuner, Durdu
dc.contributor.authorSuleyman, Halis
dc.date.accessioned2026-10-18T20:27:54.795651242Z
dc.date.available2026-10-18T20:27:54.795651242Z
dc.date.issued2021
dc.description.abstractThe current study investigates the biochemical and histopathological effects of taxifolin on acrylamide-induced kidney damage. A 50 mg/kg dose of taxifolin was administered via oral gavage to the taxifolin + acrylamide (TACR) group (n-6) consisting of male albino Wistar rats. The same volume of distilled water used as solvent was orally administered to the acrylamide (ACR) (n-6) and healthy (HG) (n-6) groups. One hour after the administration of taxifolin and distilled water, a 20 mg/kg dose of acrylamide was orally administered to the TACR and ACR groups. This procedure was repeated once a day for 30 days. In the acrylamide group, malondialdehyde (MDA), tumour necrosis factor-alpha (TNF-α), and interleukin-1 beta (IL-1β) levels were found to be high, total glutathione (tGSH) levels were found to be low, and there was severe interstitial haemorrhage; additionally, tubular necrosis, tubular atrophy, leucocyte infiltration, and glomerular structures with expanded Bowman's space were observed. In the taxifolin group, where the increase of MDA, IL-1β, and TNF-α and the decrease of tGSH associated with acrylamide have been prevented, any histopathological finding other than mild necrosis and atrophic tubules was not found. This suggests that Taxifolin would prevent kidney tissue from acrylamide-induced damage would be effective in treating acrylamide-induced nephrotoxicity, inhibiting the increase of MDA, IL-1β and TNF-α, and decreasing tGSH associated with acrylamide. © 2021
dc.identifier.doi10.1016/j.biopha.2021.111660
dc.identifier.eissn1950-6007
dc.identifier.issn0753-3322
dc.identifier.pmid34243628
dc.identifier.scopus2-s2.0-85105605060
dc.identifier.startpage111660
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/13070
dc.identifier.volume139
dc.identifier.wosWOS:000663686900008
dc.language.isoen
dc.publisherElsevier Masson s.r.l.
dc.relation.ispartofBiomedicine and Pharmacotherapy
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAcrylamide
dc.subjectKidney damage
dc.subjectRat
dc.subjectTaxifolin
dc.subjectAnimals
dc.subjectAntioxidants
dc.subjectGlutathione
dc.subjectInflammation
dc.subjectInterleukin-1beta
dc.subjectKidney
dc.subjectKidney Diseases
dc.subjectMale
dc.subjectMalondialdehyde
dc.subjectOxidative Stress
dc.subjectProtective Agents
dc.subjectQuercetin
dc.subjectRats
dc.subjectRats, Wistar
dc.subjectReactive Oxygen Species
dc.subjectTumor Necrosis Factor-alpha
dc.subjectcreatinine
dc.subjectinterleukin 1beta
dc.subjectmalonaldehyde
dc.subjecttumor necrosis factor
dc.subjectantioxidant
dc.subjectprotective agent
dc.subjectreactive oxygen metabolite
dc.subjectadult
dc.subjectanimal experiment
dc.subjectanimal model
dc.titleProtective effect of taxifolin against prooxidant and proinflammatory kidney damage associated with acrylamide in rats
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus39
rdl.citation.wos36
rdl.departmentDepartment of Physiology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan, Turkey. | Department of Pharmacology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan, Turkey. | Department of Biochemistry, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan, Turkey. | Department of Pharmacology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan, Turkey. Electronic address: halis.suleyman@gmail.com.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)